Trulieve Cannabis Corp. (TRLV)
NYSE: TRLV · Real-Time Price · USD
9.08
+0.33 (3.77%)
At close: Aug 10, 2026, 4:00 PM EDT
8.95
-0.13 (-1.43%)
After-hours: Aug 10, 2026, 7:57 PM EDT
Trulieve Cannabis Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,139 | 1,181 | 1,186 | 1,129 | 1,218 | 931.93 | |
Revenue Growth | -3.90% | -0.45% | 5.07% | -7.31% | 30.72% | 78.69% |
Cost of Revenue | 461.61 | 470.01 | 470.75 | 540.57 | 529.1 | 324.17 |
Gross Profit | 677.47 | 711.17 | 715.75 | 588.63 | 689.13 | 607.76 |
Selling, General & Admin | 432.01 | 445.21 | 510.45 | 386.16 | 446.83 | 295.53 |
Operating Expenses | 546.35 | 562.85 | 623.26 | 495.99 | 563.22 | 341.32 |
Operating Income | 131.12 | 148.32 | 92.49 | 92.64 | 125.91 | 266.44 |
Interest Expense | -56.85 | -63.45 | -62.19 | -81.57 | -73.42 | -29.12 |
Interest & Investment Income | 13.52 | 14.52 | 14.68 | 6.16 | 1.63 | 0.21 |
Other Non Operating Income (Expenses) | -406.97 | -1.37 | -7.55 | 6.54 | 2.39 | 1.11 |
EBT Excluding Unusual Items | -319.18 | 98.02 | 37.42 | 23.78 | 56.51 | 238.64 |
Merger & Restructuring Charges | - | - | - | - | -0.2 | -57.02 |
Impairment of Goodwill | - | - | - | -307.59 | - | - |
Gain (Loss) on Sale of Assets | -8.9 | -8.9 | -0.5 | -5.7 | -17.8 | -1.73 |
Asset Writedown | 3.87 | 4.07 | 5.79 | -0.96 | -57.75 | -3.64 |
Other Unusual Items | -1.72 | -1.72 | - | 5.94 | - | - |
Pretax Income | -325.93 | 91.47 | 42.71 | -284.54 | -19.24 | 176.25 |
Income Tax Expense | 144.71 | 208.11 | 197.59 | 151.36 | 163.38 | 145.72 |
Earnings From Continuing Operations | -470.64 | -116.64 | -154.88 | -435.9 | -182.62 | 30.53 |
Earnings From Discontinued Operations | -5.51 | -5.61 | -5.7 | -96.05 | -67.44 | -13.08 |
Net Income to Company | -476.15 | -122.25 | -160.58 | -531.94 | -250.06 | 17.45 |
Minority Interest in Earnings | 2.87 | 5.87 | 5.47 | 5.15 | 3.99 | 0.59 |
Net Income | -473.28 | -116.38 | -155.11 | -526.8 | -246.06 | 18.03 |
Net Income to Common | -473.28 | -116.38 | -155.11 | -526.8 | -246.06 | 18.03 |
Net Income Growth | - | - | - | - | - | -71.38% |
Shares Outstanding (Basic) | 192 | 191 | 190 | 189 | 188 | 139 |
Shares Outstanding (Diluted) | 192 | 191 | 190 | 189 | 188 | 147 |
Shares Change | 0.74% | 0.70% | 0.54% | 0.52% | 28.10% | 24.03% |
EPS (Basic) | -2.46 | -0.61 | -0.82 | -2.79 | -1.31 | 0.13 |
EPS (Diluted) | -2.47 | -0.61 | -0.82 | -2.79 | -1.31 | 0.12 |
EPS Growth | - | - | - | - | - | -77.19% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 202.53 | 228.63 | 149.18 | 167.01 | -161.32 | -297.23 |
Free Cash Flow Per Share | 1.05 | 1.20 | 0.79 | 0.88 | -0.86 | -2.02 |
Gross Margin | 59.48% | 60.21% | 60.32% | 52.13% | 56.57% | 65.22% |
Operating Margin | 11.51% | 12.56% | 7.80% | 8.20% | 10.34% | 28.59% |
Profit Margin | -41.55% | -9.85% | -13.07% | -46.65% | -20.20% | 1.93% |
Free Cash Flow Margin | 17.78% | 19.36% | 12.57% | 14.79% | -13.24% | -31.89% |
EBITDA | 301.03 | 321.73 | 258.86 | 263.3 | 300.23 | 338.61 |
EBITDA Margin | 26.43% | 27.24% | 21.82% | 23.32% | 24.64% | 36.33% |
D&A For EBITDA | 169.9 | 173.4 | 166.37 | 170.66 | 174.32 | 72.17 |
EBIT | 131.12 | 148.32 | 92.49 | 92.64 | 125.91 | 266.44 |
EBIT Margin | 11.51% | 12.56% | 7.80% | 8.20% | 10.34% | 28.59% |
Effective Tax Rate | - | 227.51% | 462.59% | - | - | 82.68% |
Advertising Expenses | - | 22.6 | 22.9 | 12.1 | 8.2 | 7.5 |